Your browser doesn't support javascript.
loading
Comparative Effectiveness of Ustekinumab and Anti-TNF Agent as First-Line Biological Therapy in Luminal Crohn's Disease: A Retrospective Study From 2 Referral Centers.
Rivière, Pauline; Kanters, Caitlyn; Pellet, Gauthier; Ni, Alexander; Hupé, Marianne; Aboulhamid, Nesrine; Poullenot, Florian; Bitton, Alain; Zerbib, Frank; Lakatos, Peter L; Afif, Waqqas; Laharie, David; Bessissow, Talat.
Afiliación
  • Rivière P; INSERM CIC 1401, Gastroenterology Department, Centre Medico-chirurgical Magellan, Hôpital Haut-Lévêque, Centre Hospitalier Universitaire de Bordeaux, Université de Bordeaux, Bordeaux, France.
  • Kanters C; Division of Gastroenterology and Hepatology, McGill University Health Centre, Montreal, Quebec, Canada.
  • Pellet G; INSERM CIC 1401, Gastroenterology Department, Centre Medico-chirurgical Magellan, Hôpital Haut-Lévêque, Centre Hospitalier Universitaire de Bordeaux, Université de Bordeaux, Bordeaux, France.
  • Ni A; Division of Gastroenterology and Hepatology, McGill University Health Centre, Montreal, Quebec, Canada.
  • Hupé M; INSERM CIC 1401, Gastroenterology Department, Centre Medico-chirurgical Magellan, Hôpital Haut-Lévêque, Centre Hospitalier Universitaire de Bordeaux, Université de Bordeaux, Bordeaux, France.
  • Aboulhamid N; Division of Gastroenterology and Hepatology, McGill University Health Centre, Montreal, Quebec, Canada.
  • Poullenot F; INSERM CIC 1401, Gastroenterology Department, Centre Medico-chirurgical Magellan, Hôpital Haut-Lévêque, Centre Hospitalier Universitaire de Bordeaux, Université de Bordeaux, Bordeaux, France.
  • Bitton A; Division of Gastroenterology and Hepatology, McGill University Health Centre, Montreal, Quebec, Canada.
  • Zerbib F; INSERM CIC 1401, Gastroenterology Department, Centre Medico-chirurgical Magellan, Hôpital Haut-Lévêque, Centre Hospitalier Universitaire de Bordeaux, Université de Bordeaux, Bordeaux, France.
  • Lakatos PL; Division of Gastroenterology and Hepatology, McGill University Health Centre, Montreal, Quebec, Canada.
  • Afif W; Division of Gastroenterology and Hepatology, McGill University Health Centre, Montreal, Quebec, Canada.
  • Laharie D; INSERM CIC 1401, Gastroenterology Department, Centre Medico-chirurgical Magellan, Hôpital Haut-Lévêque, Centre Hospitalier Universitaire de Bordeaux, Université de Bordeaux, Bordeaux, France.
  • Bessissow T; Division of Gastroenterology and Hepatology, McGill University Health Centre, Montreal, Quebec, Canada.
Inflamm Bowel Dis ; 29(6): 923-931, 2023 06 01.
Article en En | MEDLINE | ID: mdl-35917111
We conducted a retrospective real-world study to compare the efficacy of biologics in Crohn's disease. Our data suggest that an anti-tumor necrosis factor agent as a first-line biological therapy is associated with higher rates of response at 3 months than ustekinumab in Crohn's disease.
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Productos Biológicos / Enfermedad de Crohn Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Inflamm Bowel Dis Asunto de la revista: GASTROENTEROLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Francia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Productos Biológicos / Enfermedad de Crohn Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Inflamm Bowel Dis Asunto de la revista: GASTROENTEROLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Francia